1. Background
2. Objectives
3. Methods
3.1. Preparation of Plant Extracts
3.2. Oral Acute Toxicity
3.3. Assessment of In Vivo Antiplasmodial Activity (Curative Study)
3.4. Experimental Design
3.5. Determination of Plasmodial Load in Blood Samples
3.6. Hormonal Assays
3.7. Epididymal Spermatozoa Collection and Examination
3.8. Immunohistochemical Staining
3.9. Statistical Analysis
4. Results
4.1. Toxicity Effects
| Observations | Control | Azadirachta indica | |||
|---|---|---|---|---|---|
| 1 h | 2 h | 3 h | 14 Days | ||
| Consciousness | N | N | N | N | N |
| Grooming | N | N | N | N | N |
| Touch response | N | N | N | N | N |
| Sleeping duration | N | N | N | N | N |
| Movement | N | N | N | N | N |
| Gripping strength | N | N | N | N | N |
| Righting reflex | N | N | N | N | N |
| Food consumption | N | N | N | N | N |
| Water intake | N | N | N | N | N |
| Tremors | A | A | A | A | A |
| Diarrhea | A | A | A | A | A |
| Hyperactivity | A | A | A | A | A |
| Corneal reflex | N | N | N | N | N |
| Salivation | N | N | N | N | N |
| Skin colour | N | N | N | N | N |
| Lethargy | A | A | A | A | A |
| Convulsion | A | A | A | A | A |
| Sound response | N | N | N | N | N |
| Pinna reflex | N | N | N | N | N |
| Faecal appearance | N | N | P | P | N |
| Mortality | 0 | 0 | 0 | 0 | 0 |
Abbreviations: N, normal; A, absent; P, pasty.
Indicates that all the doses of ethanol leaf extract of Azadirachta indica (EEAi) significantly (P < 0.05) reduced blood parasitaemia at the end of the 4-day treatment period with EEAi, and this compared well with the standard drug. The reduced levels were sustained throughout the periods of the study (6th dpt), indicating that EEAi is parasitocidal.
4.2. Effects on Hormonal Levels
| Hormones | EEAi (mg/kg) | LDS 20 | INT | NINT | ||
|---|---|---|---|---|---|---|
| 100 | 200 | 400 | ||||
| Testosteronen (M/L) | 15.4 ± 1.3 A | 11.8 ± 0.8 A | 19.3 ± 4.5 A | 18.6 ± 3.4 A | 13.1 ± 1.2 B | 21.4 ± 1.2 A |
| AMH (ng/mL) | 21 ± 0.8 A | 38 ± 3.9 B | 14 ± 3.5 A | 14 ± 6.1 A | 22 ± 0.3 B | 14 ± 1.8 A |
| FSH (mU/mL) | 13.5 ± 2.7 A | 11.0 ± 0.7 A | 11.7 ± 1.1 A | 12.4 ± 1.0 A | 81.0 ± 6.8 B | 15.8 ± 1.9 A |
| LH (mU/M) | 10.4 ± 0.4 A | 10.4 ± 0.2 A | 7.6 ± 1.6 A | 7.6 ± 1.6 A | 7.2 ± 4.2 A | 6.3 ± 1.6 A |
Abbreviations: INT, infected not treated; NINT, not infected not treated; AMH, anti mullerian hormone; FSH, follicle stimulating hormone; LH, luteinizing hormone; LDS, Lonart®DS.
a Data are expressed as mean ± SEM for n = 5 mice/group. Different superscript capital letters show significant different.
4.3. Effects on Sperm Characteristics
| Semen Parameters | EEAi (mg/kg) | LDS 20 | INT | NINT | ||
|---|---|---|---|---|---|---|
| 100 | 200 | 400 | ||||
| Viscosity | Yes | Yes | Yes | Yes | None | Yes |
| Morphology (%) | 20 ± 0.13 A | 12.5 ± 10.6 A | 7.5 ± 3.5 A | 12.0 ± 2.5 A | 80 ± 10 A | 5 ± 0 A |
| Head (abnormal) | 13.5 ± 9.2 A | 7.5 ± 3.5 A | 10 ± 7.1 A | 17.5 ± 2.9 A | 81.7 ± 2.9 A | 15 ± 5 A |
| Tail (abnormal) | - | - | - | - | - | - |
| Volume (mL) | 1.5 ± 0 A | 1.5 ± 0 A | 1.5 ± 0 A | 1.5 ± 0 A | 0.3 ± 0.1 B | 1.5 ± 0 A |
| Sperm count | 24.5 ± 0.7 A | 20 ± 0 A | 20.5 ± 0.7 A | 24.3 ± 1.2 A | 4 ± 1 A | 26 ± 2.6 C |
| Mortility (%) | 55.5 ± 0.7 A | 67.5 ± 3.5 A | 72.5 ± 3.5 A | 66.7 ± 15.3 A | 7.3 ± 2.5 B | 80.3 ± 10.0 C |
| Viability (%) | 50.0 ± 0 A | 50.5 ± 0.7 A | 52.0 ± 1.4 A | 56.7 ± 10.7 A | 4.7 ± 2.5 B | 62.3 ± 2.5 B |
| pH of semen | 7.8 ± 0 A | 7.8 ± 0 A | 7.7 ± 0.1A | 7.5 ± 0 A | 6.0 ± 0 B | 7.5 ± 0 A |
Abbreviations: INT, Infected not treated; NINT, not infected not treated; LDS, Lonart®DS.
a Data are expressed as mean ± SEM for n = 5 mice/group. Different superscript capital letters show significant different.
4.4. Effects on Oxidative Markers
| Dose (mg/kg) | EEAi | LDS 20 | INT | NINT | ||
|---|---|---|---|---|---|---|
| 100 | 200 | 400 | ||||
| MDA (µM) | 12.6 ± 2.0 A | 14.2 ± 3.9 A | 28.1 ± 2.8 A | 15.8 ± 4.6 A | 57.0 ± 2.5 B | 16.8 ± 3.8 A |
| GSH (µM) | 8.3 ± 4.1 A | 6.7 ± 0.8 A | 11.4 ± 1.4 A | 12.1 ± 2.1 A | 0.50 ± 0.6 B | 12.5 ± 2.3 A |
| GPx (mU/mL) | 5 ± 0.1 A | 4.5 ± 0.8 A | 5.8 ± 0.2 A | 4.7 ± 1.7 A | 0.07 ± 0.02 B | 5.4 ± 0.7 A |
| SOD (U/mL) | 0.5 ± 0.03 A | 0.6 ± 0.1 A | 0.6 ± 0.06 A | 0.67 ± 0.2 A | 0.06 ± 0.02 B | 0.68 ± 0.2 A |
| CAT (U/mL) | 12.4 ± 0.3 A | 11.8 ± 1.8 A | 10.3 ± 0.4 A | 11.4 ± 1.2 A | 1.0 ± 0.3 B | 11.1 ± 0.9 A |
| NO (µmol/L) | 11.8 ± 0.8 A | 22.3 ± 11.2 A | 13.3 ± 1.6 A | 26.0 ± 3.9 A | 1.6 ± 0.4 B | 21.4 ± 9.1 A |
| TAC (µM) | 0.06 ± 0.004 A | 0.05 ± 0.004 A | 0.08 ± 0.003 A | 0.06 ± 0.01 A | 0.008 ± 0.002 B | 0.07 ± 0.01 A |
Abbreviations: MDA, malondialdehyde; GSH, glutathione; Gaps, glutathione peroxidase; SOD, superoxide dismutase; CAT, catalase; NO, nitric oxide; TAC, total antioxidant capacity; INT, infected not treated; NINT, not infected not treated; EEAi, ethanol leaf extract of Azadirachta indica; LDS, Lonart®DS.
a Data are expressed as mean ± SEM for n = 5mice/group. Different superscript capital letters show significant different.
4.5. Effects on Proliferating Cells Nuclear Antigen Expression
A, Positive control; B, (400 mg/kg A. indica + PB); C, (200 mg/kg A. Indica + PB); D, PB: Infected negative control; E, (standard control + PB + Lonart®DS); F, (100 mg/kg A.Indica + PB) showing view positive nuclear immune reaction in spermatogonia (arrows), while (D) PB infected negative control, illustrates strong positive nuclear immuno reaction in spermatogonia (arrows) for proliferating cells nuclear antigen (PCNA) immunoreaction (400 scale bar, 20 µm).
5. Discussion
| Scoring | NINT | LDS | INT | EEAi (mg/kg) | ||
|---|---|---|---|---|---|---|
| 100 | 200 | 400 | ||||
| Seminiferous tubules | 1 | 1 | 2 | 1 | 1 | 1 |
| Germinal epithelium | 1 | 1 | 3 | 1 | 1 | 1 |
| Superficial and deep cells | 1 | 2 | 4 | 2 | 1 | 1 |
| Total | 3/12 | 4/12 | 9/12 | 4/12 | 3/12 | 3/12 |
Abbreviations: INT, infected not treated; NINT, not infected not treated; EEAi, ethanol leaf extract of Azadirachta indica; LDS, Lonart®DS.
a 1 = Necrosis in superficial cells, 2 = Necrosis in superficial and deep cells with structural damage, 3 = Distal necrosis in germ cells, 4 = Disappearance of tubular structures.


